AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

A Study to Evaluate the Efficacy and Safety of TP-06 for PCED

RecruitingPhase 2Ages 18 Years - anyAllTarsus Pharmaceuticals, Inc.
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Capellion is a Phase 2 trial comparing TP-06 2.0% with Vehicle in up to 32 adults with persistent corneal epithelial defects. Participants will receive treatment for 8 weeks and be followed for 2 additional weeks to assess corneal healing and safety.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Able and willing to provide written informed consent * Presence of a non-infected persistent corneal epithelial defect (PCED) in one eye that has failed to heal after at least 10 days of appropriate standard-of-care treatment * Stable lesion size between Screening and Baseline as assessed by the Investigator Exclusion Criteria: * Active ocular infection in either eye * Corneal perforation or high risk of corneal perforation * Severe eyelid abnormalities * Ocular or eyelid surgery in the study eye within 3 months prior to Baseline (unless PCED was caused by surgery) * Use of prohibited ophthalmic medications or procedures as defined in the protocol * Any condition that, in the Investigator's judgment, would interfere with study participation or interpretation of results Note: Additional exclusion criteria apply, as defined in the protocol
๐Ÿ’Š

What it tests

  • TP-06
  • Vehicle of TP-06
๐Ÿ“

Where

14 sites
Tarsus Investigative Site
Scottsdale, United States
Tarsus Investigative Site
Tampa, United States
Tarsus Investigative Site
Atlanta, United States
Tarsus Investigative Site
Alexandria, United States
Tarsus Investigative Site
Dover, United States
Tarsus Investigative Site
Palisades Park, United States
Tarsus Investigative Site
Babylon, United States
Tarsus Investigative Site
Mt. Pleasant, United States

โ€ฆand 6 more on ClinicalTrials.gov.

๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy